Risk factors for hepatitis B virus
infection in Rio de Janeiro, Brazil Lia L Lewis-Ximenez1, 2, Kycia MR do Ó1, Cleber F Ginuino1, Jucimara C Silva1, Hermann G Schatzmayr1, Sherri Stuver2 and Clara FT Yoshida1 1National Reference Center for
Viral Hepatitis, Department of Virology, Oswaldo Cruz Institute, FIOCRUZ,
Ministry of Health, Rio de Janeiro, RJ, Brazil 2Department of Epidemiology, Harvard School of Public Health,
Boston, Ma, USA
Despite international efforts to prevent hepatitis B
virus (HBV) infection through global vaccination programs, new cases are
still being reported throughout the world.
Methods
To supply data that might assist in improving preventive
measures and national surveillance for HBV infection, a cross-sectional
study was conducted among individuals referred to the Brazilian National
Reference Center for Viral Hepatitis (Rio de Janeiro) during a two-year
period. Reported risk factors among infected subjects ("HBV-positive") were
compared to those of subjects never exposed ("HBV-negative") to HBV. Two
subgroups were further identified within the HBV-positive group, "acute"
infection and "non-acute" infection.
Results
A total of 1,539 subjects were tested for HBV, of which
616 were HBV-positive (79 acute infection and 537 non-acute infection). HBV-positive
subjects were more likely to be of male gender (63% versus 47%); and to
report multiple sexual partners (12% versus 6%) and illicit drug use (IDU
and/or intranasal cocaine use) (6% versus 3%). Among the HBV-positive
subgroups, age differed significantly, with 48% being under 30 years of age
in subjects acutely infected compared to 17% in those with non-acute
infection.
Conclusions
The association of multiple sexual partners with past HBV
infection and the age distribution of currently infected subjects suggest
that sexual transmission played a major role in the transmission of HBV in
this study population. Thus, vaccination during adolescence should be
considered.
Hepatitis B, a global but preventable disease, is
estimated to affect at least 300 million individuals throughout the world.
National vaccination programs have been encouraged since 1989 [1]
, and many countries have already shown the impact of these programs in
preventing chronic hepatitis B virus (HBV) infection, and consequently
hepatocellular carcinoma [2-4] , as well as their possible
cost effectiveness [5,6] . Not all
countries, however, have been able to implement hepatitis B vaccination on a
national level, and only in 1998 has it been included in Brazil's national
infant immunization calendar. In 1997, the Brazilian National Reference
Center for Viral Hepatitis (BNRCVH), located in the coastal Southeastern
region of Brazil (Rio de Janeiro), established a patient referral site in
response to the gradual increase of referred individuals from public and
private hospitals and clinics, and blood banks. The referral site has been
engaged in diagnostic testing for viral hepatitis, obtaining data from
epidemiologic questionnaires, and tracking partners and household members at
risk of hepatitis infection since its establishment. In the present paper,
major risk factors of HBV infection are described based on subjects seen at
the BNRCVH, with the objective of providing data that might help to improve
preventive measures and national surveillance.
The study population consisted of all subjects registered
at the BNRCVH's patient referral site between September 1997 and September
1999, who were tested for HBV serological markers. Interviewers used
standardized questionnaires to obtain data on demographic characteristics
and risk factors for parenteral and sexual exposure to HBV. Ten risk factors
queried in the questionnaire were selected for analysis and included history
of: blood transfusion, surgery, hemodialysis, occupation as a health
professional, intravenous drug use (IDU), intranasal cocaine use, tattoos,
sexually transmitted diseases (STD), multiple sexual partners (more than
five sexual partners/year), and male homosexuality.
Demographic variables such as gender, age, educational
and economic status, and residency were also assessed. Age was categorized
by decades into eight groups, with the youngest group being under eleven
years and the oldest group over 60 years. Educational status was categorized
into two groups: those that were illiterate or had at most completed primary
education and those who had studied beyond primary school. Economic status
also was categorized into two groups: individuals with a monthly income of
less than three minimum Brazilian salaries, which is equivalent to
approximately U$ 225, and those with higher wages. Residency was
dichotomised as those living in the mostly densely populated region of Rio
de Janeiro County (northern region) and those living elsewhere.
Laboratory testing
Testing for present or past HBV infection included
hepatitis B surface antigen (HBsAg), antibody to HBsAg (anti-HBs),
antibodies to hepatitis B core (IgM anti-HBc, total anti-HBc), hepatitis B e
antigen (HBeAg), and antibody to HBeAg (anti-HBe) (Organon Teknika, Boxtel,
The Netherlands; and Bio-Manguinhos, FIOCRUZ, Brazil). Testing of alanine
aminotransferase (ALT) levels was also performed.
HBV infection status: groups and
subgroups
To evaluate the potential risk factors in subjects with
different HBV infection status, individuals were categorized into two
groups, HBV-positive and HBV-negative groups. The HBV-positive group was
comprised of subjects who tested positive for any HBV marker and the HBV-negative
group tested negative for all markers. Individuals who had isolated anti-HBs
were excluded since it may represent hepatitis B vaccine response. To
identify current trends in transmission routes of HBV infection the HBV-positive
group was subsequently divided into two subgroups: those with acute HBV
infection and those with non-acute HBV infection. The acute infection
subgroup included individuals with present infection, who tested positive
for IgM anti-HBc with or without HBsAg. The non-acute infection subgroup
comprised of subjects with chronic or past infection who were negative for
IgM anti-HBc. Chronic infection was confirmed by HBsAg positivity and past
infection with anti-HBc. Subjects with clinical symptoms (i.e., jaundice,
choluria) were classified as symptomatic, and those with very mild or no
symptoms were considered asymptomatic.
Statistical analysis
Mean values for age and median values for ALT (non-normal
distribution) were compared between the HBV groups using the t-test and the
Kruskal-Wallis test, as appropriate. The Chi-square test was used to
evaluate gender distribution differences. To assess the association between
risk factors and HBV infection status, a multivariate analysis was used to
adjust for age (continuous) and gender. The adjusted prevalence ratios were
estimated through a binomial regression model using the log-link function in
STATA 6 (Stata Corporation, College Station, Texas) [7] .
Table 1
Distribution of HBV infection according
to age and clinical status
Table 2
Prevalence ratios* for risk factors in
HBV-positive and HBV-negative groups.
Demographics
During these two years (1997 1999), the BNRCVH
registered 1,539 subjects who were tested for HBV infection. The mean age of
these subjects was 38 years (range: 19 days 86 years). Almost 67 percent
had at most a primary school education, and 55 percent received a monthly
income of less than three minimum salaries. Most subjects living in Rio de
Janeiro County were from the highly populated area located in the northern
region, and those from other counties lived mostly in neighbourhood counties
that bordered this region. Among the 1,539 subjects evaluated, 616 (40%)
were HBV-positive and 923 (60%) were HBV-negative. Both groups shared
similar referral profiles with liver disease being the most predominant
motive. In the HBV-positive group, 79 (13%) had acute infection and 537
(87%) had non-acute infection.
The mean ages for the HBV-positive and the HBV-negative
groups did not differ significantly and were 42 and 37, respectively. The
mean ages for the HBV-positive subgroups were 32 for acute infection and 43
for non-acute infection (P < 0.0001). Table
1 summarizes age distribution among individuals infected with HBV
according to their different infection status (acute infection versus
non-acute infection).
Acute HBV infection
Seventy nine subjects were acutely infected with HBV, 52
males (66%) and 27 females (34%), with an average age of 32 (± 14). Among
the cases of acute hepatitis, 77% (61/79) were symptomatic with the
remaining detected during family tracking. HBsAg was absent in 17/79 (22%)
with IgM anti-HBc as the only indicator of active infection on at least two
different samples tested.
Risk factors
Differences in the distribution of risk factors were
compared between the HBV-positive and -negative groups, with similarities
observed for educational level, economic status, and residency (table
2). Higher frequencies were observed in the HBV-positive group for
history of blood transfusion (15% versus 14%), surgery (40% versus 37%),
hemodialysis (9% versus 8%), IDU (1% versus 0.5%), intranasal cocaine use
(5% versus 3%), tattooing (4% versus 3%), STD (10% versus 7%), multiple
sexual partners (12% versus 6%), and homosexuality (3% versus 2%). Adjusted
prevalence ratios (table
2) demonstrated HBV-positivity to be associated with history of multiple
partners when compared to the HBV-negative group. Although the associations
between IDU and intranasal cocaine use and HBV-positivity were not
statistically significant, a significant association was obtained when
pooling these two variables in the analysis (PR = 1.8, 95% CI 1.1 3.0, p =
0.04).
Risk factors compared between the acute and non-acute HBV
infection subgroups were similar (data not shown). Sexual or household
contact was reported in 26 (33%) subjects with acute infection. Other routes
of transmission reported among those acutely infected were: intranasal
cocaine use (8%), being a hemodialysis patient (5%), and being a health
professional without previous vaccination (5%).
Brazil, the fifth largest country in the world, is
divided into five geographic regions which carry different endemic patterns
for HBV infection with a prevalence increasing from south to north [8]
. The Southeast region occupies only 11% of the national territory but
nevertheless, 43% of the population, and has a low endemic pattern for HBV
infection [9,10] . In low-risk areas
the highest incidence of HBV infection is observed in adolescents and young
adults, while in more endemic areas most infections occur in children. In
the present study, the significant age difference observed between the acute
and non-acute HBV infection subgroups, suggests the low endemic pattern in
which adolescents and young adults have a lower frequency of HBV antibodies
and are more prone to infection via sexual activity and high-risk behaviours
such as drug use. In 1996, the highest number of HBV cases notified to the
Brazilian National Health Foundation was between the ages 20 and 49 years [11]
. An identical age distribution was observed at the BNRCVH among subjects
acutely infected with HBV, with the highest numbers occurring in the age
groups 21 to 50 years. Multiple sexual partners or history of STD was not
uncommonly reported (22%) in these age groups, which suggests a role for
sexual transmission of HBV in this population. Even though fewer cases of
current infection were observed in subjects in the 11 to 20 age category,
they had a higher proportion (64%) of acute cases when compared to older age
groups, whose proportions ranged from 18% to 46%.
Male gender also seemed to play an important role in the
acquisition of HBV infection. There were approximately twice as many males
as females with acute HBV infection. Previous studies have demonstrated that
men are more likely to become chronic HBV carriers than women [12]
. However, the gender difference in the acute cases might also reflect the
increased frequency of high-risk behavior, such as multiple sexual partners
and drug use among men compared to women.
The lack of association observed with IDU and HBV
infection may have been due to under reporting. Intranasal use of cocaine
alone may be a transmission route since it is not uncommon for a few to have
reported nasal bleeding following the procedure.
Even though the study was not population-based our
findings are in accordance with published data, such as having multiple sex
partners and illicit drug use [13-16] .
Due to the high concentration of circulating HBV and the
virus's ability to remain viable on environmental surfaces for more than a
week [17] , hemodialysis patients are especially at high
risk of acquiring HBV infection. This was demonstrated again in this study
where even though most of our hemodialysis patients with documented HBV
infection were chronic carriers, four were acutely infected. The continued
association between hemodialysis and HBV infection suggests that some
hemodialysis facilities have failed to completely implement the recommended
infection control measures. Sporadic outbreaks are still being and will
continue to be reported in these facilities [18] .
Conclusions
In summary, the age categories in which most new cases
of HBV infection occurred together with the associations observed between
multiple sexual partners and HBV infection strongly suggest that unsafe
sexual behavior plays a major role in transmitting HBV infection in this
study group. Moreover, since hemodialysis facilities may still be hazardous
environments for acquiring blood-borne diseases, infection control practices
should be intensified jointly with continuous education of health-care
workers. The results from this study also support the extension of HBV
vaccination to early adolescence to prevent sexual transmission.
Authors' contributions
Author 1 (LLL-X) designed and coordinated the study,
performed the statistical analysis and drafted the manuscript. Author 2 (KMRO)
participated in attending the patients and was responsible for obtaining
confidential information from the questionnaires. Author 3 (CFG) carried out
the immunoassays and interviewed patients. Author 4 (JCS) carried out the
immunoassays and interviewed patients. Author 5 (HGS) participated in
drafting the manuscript. Author 6 (SS) participated in the design of the
questionnaires, statistical analysis and in the drafting of the manuscript.
Author 7 (CFTY) participated in the design of the study.
All authors read and approved the final manuscript.
Competing interests
None declared.
Acknowledgements
We are indebted to the Evandro Chagas Hospital/FIOCRUZ
for providing the rooms for blood withdrawals and interviews, and for
performing the ALT testing for all referred subjects. This study was
supported in part in Brazil by FAPERJ, CNPq, and COLAB/MS and in the USA by
a grant (TW00918) from the Fogarty International Institute of the National
Institutes of Health.
Maynard JE,
Kane MA, Hadler SC: Global control of hepatitis B through
vaccination: role of hepatitis B vaccine in the Expanded Programme on
Immunization. Rev Infect Dis 1989, 11(suppl 3):S574-S578 [PubMed
Abstract]
Da Villa G:
Rationale for the infant and adolescent vaccination programmes in
Italy. Vaccine 2000, 18(suppl 1):S31-S34 [PubMed
Abstract][Publisher
Full Text]
Mulley AG,
Silverstein MD, Dienstag JL: Indications for use of hepatitis B
vaccine, based on cost-effectiveness analysis, N Engl J Med 1982, 307:644-652 [PubMed
Abstract]
Juarez E,
do Amaral Junior C, Pinheiro F, Biellik R: Hepatitis B and delta
vaccination program in the western Amazon region of Brazil. Prog Clin Biol Res 1991, 364:343-349 [PubMed
Abstract]
Martelli
CMT, Turchi MD, Souto FJ, Sáez-Alquézar A, Andrade ALSS, Zicker F:
Anti-HBc testing for blood donors in areas with intermediate hepatitis B
endemicity. Rev Panam Salud Publica 1999, 6:69-73 [PubMed
Abstract][Publisher
Full Text]
Silveira TR,
da Fonseca JC, Rivera L, et al.: Hepatitis B seroprevalence in
Latin America. Rev Panam Salud Publica 1999, 6:378-383 [PubMed
Abstract][Publisher
Full Text]
Szmuness W,
Much I, Prince AM, et al.: On the role of sexual behavior in
the spread of hepatitis B infection. Ann Intern Med 1975, 83:489-495 [PubMed
Abstract]
Nordenfelt
E, Lindholm T, Dahlquist E: A hepatitis epidemic in a dialysis unit.
Occurrence and persistence of Australia-antigen among patients and
staff. Acta Pathol Microbiol Scand [B] Microbiol Immunol 1970, 78:692-700
[PubMed
Abstract]
Knight AH,
Fox RA, Baillod RA, Niazi SP, Sherlock S, Moorhead JF:
Hepatitis-associated antigen and antibody in haemodialysis patients and
staff. Br Med J 1970, 3:603-606 [PubMed
Abstract]
Favero MS,
Bond WW, Petersen NJ, Berquist KR, Maynard JE: Detection methods for
study of the stability of hepatitis B antigen on surfaces. J Infect Dis 1974, 129:210-212 [PubMed
Abstract]
Lewis-Ximenez
LL, Oliveira JM, Mercadante LAC, et al.: Serological and
Vaccination Profile of Hemodialysis Patients during an Outbreak of
Hepatitis B Virus Infection. Nephron 2001, 87:19-26 [PubMed
Abstract][Publisher
Full Text]
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
"A foolish faith in authority is the worst enemy of truth."
-- Albert Einstein, letter to a friend, 1901
"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."
-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820
"What's the point of vaccination if it doesn't protect you from the unvaccinated?"
-- Sandy Gottstein
"Who gets to decide what the greater good is and how many will be sacrificed to it?"